Table 1

WHO strategies for azithromycin mass drug administration (MDA) in children

DiseasesPurpose of MDALocationWHO recommended doseWHO recommended frequencyWHO recommended durationCombination intervention
TrachomaControlDistricts with TF1-9*≥5%20 mg/kg up to 1 gAnnuallyAt least three doses (years) where TF1-9*≥10%SAFE†
YawsEradicationYaws-endemic areas30 mg/kg up to 2 gAnnuallyOne single doseNone
  • *TF in children aged 1–9 years.

  • †Surgery for trichiasis, antibiotic treatment, facial cleanliness and environmental improvement.

  • TF, trachomatous inflammation-follicular.